2 days ago
Fidelity National Information Services reported third quarter 2026 sales of US$3.45b and net income of US$356m, and also affirmed a US$0.44 quarterly dividend payable in late December.
The business paired stronger earnings with a lower 2026 outlook, paused buybacks to cut debt, and announced CFO James Kehoe's departure, which sharpened the focus on execution and balance sheet discipline.
We will now look at how Fidelity National Information Services' lowered guidance and CFO transition could reshape the broader investment narrative.
Spot 30 resilient stocks with low risk scores that pair steadier balance sheets with more predictable outlooks if Fidelity National Information Services' guidance cut and CFO change leave you wanting a smoother ride.
For an investor to stay with Fidelity National Information Services, the core belief is that its mix of banking, payments and capital markets software can keep shifting toward higher margin, recurring contracts, even as client behavior gets choppier. The Q3 2026 report supports that thesis on execution, with higher sales, stronger net income and better earnings per share from continuing operations.
#national
The business paired stronger earnings with a lower 2026 outlook, paused buybacks to cut debt, and announced CFO James Kehoe's departure, which sharpened the focus on execution and balance sheet discipline.
We will now look at how Fidelity National Information Services' lowered guidance and CFO transition could reshape the broader investment narrative.
Spot 30 resilient stocks with low risk scores that pair steadier balance sheets with more predictable outlooks if Fidelity National Information Services' guidance cut and CFO change leave you wanting a smoother ride.
For an investor to stay with Fidelity National Information Services, the core belief is that its mix of banking, payments and capital markets software can keep shifting toward higher margin, recurring contracts, even as client behavior gets choppier. The Q3 2026 report supports that thesis on execution, with higher sales, stronger net income and better earnings per share from continuing operations.
#national
7 days ago
PARIS (AP) — The Dakar Rally in January will start in Portugal and finish in Morocco after being moved from Saudi Arabia because of the Middle East conflict.
Organizers announced the new route on Friday. They canceled the race in Saudi last weekend but reaffirmed it will return to the kingdom in 2028.
The Dakar, the world's biggest off-road race, returns to Africa for the first time in 20 years.
It will run from Jan. 9-23. The Algarve will hold the prologue and first stage and Morocco will hold the other 11 stages, going as south as outside Dakhla with a return north to finish in Marrakech.
Organizers said the route was 7,824 kilometers with 4,341 of those special stages, which was close to recent editions. Each special will range from 350 to 500 kilometers.
#dakar #race #hold
Organizers announced the new route on Friday. They canceled the race in Saudi last weekend but reaffirmed it will return to the kingdom in 2028.
The Dakar, the world's biggest off-road race, returns to Africa for the first time in 20 years.
It will run from Jan. 9-23. The Algarve will hold the prologue and first stage and Morocco will hold the other 11 stages, going as south as outside Dakhla with a return north to finish in Marrakech.
Organizers said the route was 7,824 kilometers with 4,341 of those special stages, which was close to recent editions. Each special will range from 350 to 500 kilometers.
#dakar #race #hold
7 days ago
Lewis Hamilton says he is unlike any driver Formula 1 has seen before and reaffirmed a determination to keep racing into his mid-forties.
The seven-time world champion recently said he wanted to continue in the sport to fulfil a dream of racing in Africa, having campaigned for a Grand Prix there for many years.
F1 has signed a 10-year deal with the central-east African country of Rwanda starting in the early 2030s which will be a first race on the continent since 1993.
Hamilton is 41 and will be at least 45 when that race takes place, but he told a news conference before this weekend's Mexico Grand Prix that he should be considered a special case.
The Briton said F1 had "never had anyone like me in the 70 years" of the sport and he felt like he was "built differently".
#grand #race
The seven-time world champion recently said he wanted to continue in the sport to fulfil a dream of racing in Africa, having campaigned for a Grand Prix there for many years.
F1 has signed a 10-year deal with the central-east African country of Rwanda starting in the early 2030s which will be a first race on the continent since 1993.
Hamilton is 41 and will be at least 45 when that race takes place, but he told a news conference before this weekend's Mexico Grand Prix that he should be considered a special case.
The Briton said F1 had "never had anyone like me in the 70 years" of the sport and he felt like he was "built differently".
#grand #race
11 days ago
Meghan Markle is reportedly planning to challenge Prince William and Kate Middleton. According to sources, the Sussexes are facing new tensions with the monarchy after the King issued a letter reaffirming their status as "non-working royals." As such, Markle is allegedly planning to share more royal secrets in her upcoming projects.
According to OK! Magazine, Meghan Markle is ready to fight Prince William and Kate Middleton after a letter confirming the Sussexes' status. "Meghan suspects William influenced his father's decision to put her and Harry in their place, and believes Kate supported the move," a royal insider told the publication.
The insider continued, "Meghan has correctly interpreted the Palace's position as an attempt to reinforce the Sussexes' exclusion from official royal life." This is "despite their apparent efforts to improve family relations."
However, "she is now ready to take on William and Kate, and fight back against them by spilling even more royal secrets in her future streaming projects." The ******* ss of Sussex "thinks she has nothing to lose now." Another source said, "Meghan believes she and Harry should respond more ******* ertively to negative publicity."
They continued, "The Sussexes could increasingly use their own professional relationships and communications platforms to explain their position." This means "more documentaries and takedowns of the royal family from their U.K. home."
#royal #markle #according
According to OK! Magazine, Meghan Markle is ready to fight Prince William and Kate Middleton after a letter confirming the Sussexes' status. "Meghan suspects William influenced his father's decision to put her and Harry in their place, and believes Kate supported the move," a royal insider told the publication.
The insider continued, "Meghan has correctly interpreted the Palace's position as an attempt to reinforce the Sussexes' exclusion from official royal life." This is "despite their apparent efforts to improve family relations."
However, "she is now ready to take on William and Kate, and fight back against them by spilling even more royal secrets in her future streaming projects." The ******* ss of Sussex "thinks she has nothing to lose now." Another source said, "Meghan believes she and Harry should respond more ******* ertively to negative publicity."
They continued, "The Sussexes could increasingly use their own professional relationships and communications platforms to explain their position." This means "more documentaries and takedowns of the royal family from their U.K. home."
#royal #markle #according
18 days ago
Joe Mazzulla declares Payton Pritchard will be key to Jayson Tatum-led Celtics' success originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by clicking here.
When you lose a key player in the offseason, the question remains: who fills that production hole? The Boston Celtics do not seem to worry about this conundrum at all. With Jaylen Brown gone, they have filled all the gaps by committee. Hugo Gonzalez and Baylor Scheierman get to play both ends with hustle. Paul George still has that fringe NBA All-Star quality and can shoot the lights out. However, Coach Joe Mazzulla is looking at a key player. It's none other than Payton Pritchard. The Celtics head coach has all the belief in their guard and even noted specific traits that will make him helpful to the squad led by Jayson Tatum.
For a long time, a few monoliths have described Payton Pritchard. He's been seen as the Celtics' offensive spark plug, or the guy you give the ball to in the clutch. Now, he will be up for bigger roles in Coach Joe Mazzulla's system due to the Jaylen Brown trade.
There are obviously a lot of doubts about Pritchard. Much of it stems from the fact that he's an undersized guard and the running belief that he could be a defensive liability. Coach Mazzulla does not think that way at all. In fact, the Celtics head honcho outlined what made their veteran guard special. Those same traits could also make a big difference on a team centered around Jayson Tatum, according to Jay King of The Athletic.
"He just plays with a chip on his shoulder, but doesn't have an ego. And I think that's a balance that's difficult for people to be able to have. Like, if you tell him he's starting, if you tell him he's coming off the bench, if you tell him he's playing 20 (minutes), if you tell him he's playing 30, the chip on his shoulder never changes. He doesn't need the affirmation to be an elite competitor. And so I think a coach that gives you the freedom to just do what makes the most sense at that particular time," the Celtics head coach declared.
#payton #tatum #guard
When you lose a key player in the offseason, the question remains: who fills that production hole? The Boston Celtics do not seem to worry about this conundrum at all. With Jaylen Brown gone, they have filled all the gaps by committee. Hugo Gonzalez and Baylor Scheierman get to play both ends with hustle. Paul George still has that fringe NBA All-Star quality and can shoot the lights out. However, Coach Joe Mazzulla is looking at a key player. It's none other than Payton Pritchard. The Celtics head coach has all the belief in their guard and even noted specific traits that will make him helpful to the squad led by Jayson Tatum.
For a long time, a few monoliths have described Payton Pritchard. He's been seen as the Celtics' offensive spark plug, or the guy you give the ball to in the clutch. Now, he will be up for bigger roles in Coach Joe Mazzulla's system due to the Jaylen Brown trade.
There are obviously a lot of doubts about Pritchard. Much of it stems from the fact that he's an undersized guard and the running belief that he could be a defensive liability. Coach Mazzulla does not think that way at all. In fact, the Celtics head honcho outlined what made their veteran guard special. Those same traits could also make a big difference on a team centered around Jayson Tatum, according to Jay King of The Athletic.
"He just plays with a chip on his shoulder, but doesn't have an ego. And I think that's a balance that's difficult for people to be able to have. Like, if you tell him he's starting, if you tell him he's coming off the bench, if you tell him he's playing 20 (minutes), if you tell him he's playing 30, the chip on his shoulder never changes. He doesn't need the affirmation to be an elite competitor. And so I think a coach that gives you the freedom to just do what makes the most sense at that particular time," the Celtics head coach declared.
#payton #tatum #guard
1 month ago
In late September 2026, AT&S Austria Technologie & Systemtechnik AG announced an expanded collaboration with Marvell Technology to increase advanced IC substrate capacity for next-generation AI and cloud infrastructure, while Marvell also affirmed a quarterly dividend of US$0.06 per share payable on October 29, 2026.
This deeper manufacturing partnership gives Marvell greater access to complex packaging technologies that are increasingly critical for high-performance AI chips and data center hardware.
Next, we'll examine how this expanded AT&S manufacturing capacity could influence Marvell's AI-focused growth story and longer-term investment narrative.
The future of work is here. Discover the 89 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
To own Marvell, you need to believe its AI and data center franchises can justify today's rich valuation and eventually translate into stronger, more consistent earnings power. The expanded AT&S IC substrate deal directly supports Marvell's near term AI optics and custom silicon ramp, while also amplifying the existing risk that long term supplier prepayments and capacity commitments could weigh on margins and free cash flow if AI demand or customer ramps slow.
#term #substrate #Manufacturing #data
This deeper manufacturing partnership gives Marvell greater access to complex packaging technologies that are increasingly critical for high-performance AI chips and data center hardware.
Next, we'll examine how this expanded AT&S manufacturing capacity could influence Marvell's AI-focused growth story and longer-term investment narrative.
The future of work is here. Discover the 89 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
To own Marvell, you need to believe its AI and data center franchises can justify today's rich valuation and eventually translate into stronger, more consistent earnings power. The expanded AT&S IC substrate deal directly supports Marvell's near term AI optics and custom silicon ramp, while also amplifying the existing risk that long term supplier prepayments and capacity commitments could weigh on margins and free cash flow if AI demand or customer ramps slow.
#term #substrate #Manufacturing #data
2 months ago
Marathon Petroleum Corporation (NYSE:MPC) has substantially outperformed the wider market this year, supported by an unusually sharp surge in global refining margins as the prolonged Iran crisis has significantly tightened global refining capacity and reduced supplies of gasoline, diesel, and jet fuel.
With Marathon up by over 150% since the beginning of 2026, there are now concerns that the stock may have topped out. However, the ****** ysts over at Morgan Stanley are convinced that the rally still has further room to run. On September 14, Morgan Stanley ****** yst Joe Laetsch significantly raised the firm's price target on MPC from $265 to $453, while reaffirming an 'Overweight' rating on the shares.
The target boost reflects an upside of over 9% from the current price level and even exceeds the stock's record high of just under $411 per share achieved earlier this month. The Morgan Stanley update comes amid broader Wall Street optimism surrounding the American refining giant, with ****** ysts from Raymon James, UBS, and several others also improving their respective outlooks on MPC.
Morgan Stanley's vote of confidence suggests that Wall Street expects the ongoing refining upcycle to last longer than previously expected, especially given the fresh wave of attacks between Washington and Tehran. Even if the conflict in the Middle East subsides, the region's refined fuel output is expected to remain relatively tight, since the damaged or idled refineries in the Middle East are likely to take some time to return to full operations.
As the largest refiner by volume in the United States, Marathon has significant operating leverage to capitalize on the current high-margin environment. The company already demonstrated its ability to translate the high crack spreads into material earnings when it delivered an almost fourfold increase in profits in the second quarter.
#morgan #marathon #stanley #middle
With Marathon up by over 150% since the beginning of 2026, there are now concerns that the stock may have topped out. However, the ****** ysts over at Morgan Stanley are convinced that the rally still has further room to run. On September 14, Morgan Stanley ****** yst Joe Laetsch significantly raised the firm's price target on MPC from $265 to $453, while reaffirming an 'Overweight' rating on the shares.
The target boost reflects an upside of over 9% from the current price level and even exceeds the stock's record high of just under $411 per share achieved earlier this month. The Morgan Stanley update comes amid broader Wall Street optimism surrounding the American refining giant, with ****** ysts from Raymon James, UBS, and several others also improving their respective outlooks on MPC.
Morgan Stanley's vote of confidence suggests that Wall Street expects the ongoing refining upcycle to last longer than previously expected, especially given the fresh wave of attacks between Washington and Tehran. Even if the conflict in the Middle East subsides, the region's refined fuel output is expected to remain relatively tight, since the damaged or idled refineries in the Middle East are likely to take some time to return to full operations.
As the largest refiner by volume in the United States, Marathon has significant operating leverage to capitalize on the current high-margin environment. The company already demonstrated its ability to translate the high crack spreads into material earnings when it delivered an almost fourfold increase in profits in the second quarter.
#morgan #marathon #stanley #middle
2 months ago
On September 14, NextEra Energy, Inc. (NYSE:NEE) and Dominion Energy, Inc. (NYSE:D) announced a "transformational" Virginia benefits package to address concerns regarding their proposed $66.8 billion merger. The Virginia supplier program, worth up to $1 billion annually for five years, will direct spending toward contractors, suppliers, and service providers in the state.
Additionally, the companies also proposed doubling residential bill credits to four years, protecting retail customers from grid costs tied to Northern Virginia's rapidly expanding AI data centers, and committing $100 million toward directly supporting workforce development in the Commonwealth. NextEra also stated that it plans to add 600 new energy jobs in Virginia, while expecting suppliers to create another 400 positions.
The updated package comes after the proposed merger attracted a great deal of political scrutiny due to the impact it can have on everyday consumers. Virginia Governor Abigail Spanberger also stated last month that she would formally intervene in the regulatory review to press for commitments on electric bill affordability, job protections, and clean-energy investments.
John Ketchum, Chairman, President, and CEO of NextEra Energy, commented:
"This is a Virginia-first package, and it starts with customers. We are proposing to double residential bill relief from two years to four years, along with expanded low-income financial ******* istance and long-term affordability benefits. We are also reaffirming our support for the State Corporation Commission, Governor and General ******* embly's efforts to protect residential and small business customers from costs ******* ociated with serving data centers. Just as important, this package would help Virginia build more of the clean energy and infrastructure it needs faster, so the Commonwealth can reduce its reliance on expensive imported power. And it would do that while positioning Virginia as a major energy leader, bringing NextEra Energy jobs, good-paying supplier jobs, workforce investment, economic development and national-scale energy technology and innovation to Virginia. This is the kind of customer-focused, job-creating package this combination makes possible."
#energy #years #Jobs
Additionally, the companies also proposed doubling residential bill credits to four years, protecting retail customers from grid costs tied to Northern Virginia's rapidly expanding AI data centers, and committing $100 million toward directly supporting workforce development in the Commonwealth. NextEra also stated that it plans to add 600 new energy jobs in Virginia, while expecting suppliers to create another 400 positions.
The updated package comes after the proposed merger attracted a great deal of political scrutiny due to the impact it can have on everyday consumers. Virginia Governor Abigail Spanberger also stated last month that she would formally intervene in the regulatory review to press for commitments on electric bill affordability, job protections, and clean-energy investments.
John Ketchum, Chairman, President, and CEO of NextEra Energy, commented:
"This is a Virginia-first package, and it starts with customers. We are proposing to double residential bill relief from two years to four years, along with expanded low-income financial ******* istance and long-term affordability benefits. We are also reaffirming our support for the State Corporation Commission, Governor and General ******* embly's efforts to protect residential and small business customers from costs ******* ociated with serving data centers. Just as important, this package would help Virginia build more of the clean energy and infrastructure it needs faster, so the Commonwealth can reduce its reliance on expensive imported power. And it would do that while positioning Virginia as a major energy leader, bringing NextEra Energy jobs, good-paying supplier jobs, workforce investment, economic development and national-scale energy technology and innovation to Virginia. This is the kind of customer-focused, job-creating package this combination makes possible."
#energy #years #Jobs
2 months ago
Affirm Holdings, Inc. (NASDAQ:AFRM) has underperformed the broader market year to date, but the tide is slowly turning. Robust growth in interest-bearing loans, a strategic partnership with Shopify in Australia, and accelerating volumes at Amazon provide multiple avenues for continued growth.
On September 12, Goldman Sachs raised its price target to $115 from $106, citing improving underlying fundamentals. The hike follows the company's impressive fourth-quarter fiscal 2026 results, with revenues surging 33% to $1.2 billion and operating income rising $89 million to $147 million.
The robust revenue growth came as the company continued to attract more business interest-bearing loans. Interest income rose 35% in the fourth quarter, in line with a 33% increase in average net loans held for investment partners. More importantly, 80% of Affirm's direct-to-consumer product loans carried interest at quarter-end, giving the company an increasingly meaningful source of recurring interest income.
The investment bank has also touted the growth opportunity around Affirm Card, which is helping the company expand its relationship with consumers beyond individual BNPL transactions. Active cardholders more than doubled to 5.2 million, resulting in a 124% increase in Card GMV to $2.8 billion.
Management has already hinted at continued upside momentum by estimating a massive increase in GMV to $64 billion in fiscal 2027 and an adjusted operating margin of 30.5%. Against this backdrop, Wolfe Research ****** yst Darrin Peller upgraded the stock to Outperform with a $90 price target. According to the ****** yst, Affirm Holdings is a winner in the point-of-sale financing ****** e.
#interest #billion #company
On September 12, Goldman Sachs raised its price target to $115 from $106, citing improving underlying fundamentals. The hike follows the company's impressive fourth-quarter fiscal 2026 results, with revenues surging 33% to $1.2 billion and operating income rising $89 million to $147 million.
The robust revenue growth came as the company continued to attract more business interest-bearing loans. Interest income rose 35% in the fourth quarter, in line with a 33% increase in average net loans held for investment partners. More importantly, 80% of Affirm's direct-to-consumer product loans carried interest at quarter-end, giving the company an increasingly meaningful source of recurring interest income.
The investment bank has also touted the growth opportunity around Affirm Card, which is helping the company expand its relationship with consumers beyond individual BNPL transactions. Active cardholders more than doubled to 5.2 million, resulting in a 124% increase in Card GMV to $2.8 billion.
Management has already hinted at continued upside momentum by estimating a massive increase in GMV to $64 billion in fiscal 2027 and an adjusted operating margin of 30.5%. Against this backdrop, Wolfe Research ****** yst Darrin Peller upgraded the stock to Outperform with a $90 price target. According to the ****** yst, Affirm Holdings is a winner in the point-of-sale financing ****** e.
#interest #billion #company
2 months ago
NextEra Energy, Inc. (NYSE:NEE) has outlined its growth targets for 2026 and beyond. This comes as the company advances plans to acquire Dominion Energy Inc (NYSE:D). It's a $67 billion all-stock transaction expected to close before the end of next year. If the merger is completed as expected, it would result in the largest US electricity producer.
NextEra's business is already growing, and Dominion is expected to increase the growth rate. The deal's promise is exciting, but its value to investors ultimately depends on NextEra securing regulatory approvals and successfully integrating Dominion ***** ets.
NextEra Energy, Inc. (NYSE:NEE) has reaffirmed its 2026 adjusted EPS guidance of $3.92 to $4.02 and said it was targeting the high end of that range. NextEra also said it expects adjusted EPS to grow at a compound annual rate of at least 8% through 2032 and is targeting the same growth rate through 2035, off the 2025 base.
NextEra also plans to continue rewarding its shareholders with higher dividends. The company expects its dividend per share to grow at a roughly 10% annual rate through 2026, off the 2024 base. It expects the dividend to grow 6% a year through 2028 from the 2026 base.
The EPS and dividend growth projections give investors a financial foundation for evaluating the Dominion deal. NextEra does not need Dominion simply to prevent a growth slowdown. Instead, it's looking to add another growth engine through the acquisition.
#dominion #rate
NextEra's business is already growing, and Dominion is expected to increase the growth rate. The deal's promise is exciting, but its value to investors ultimately depends on NextEra securing regulatory approvals and successfully integrating Dominion ***** ets.
NextEra Energy, Inc. (NYSE:NEE) has reaffirmed its 2026 adjusted EPS guidance of $3.92 to $4.02 and said it was targeting the high end of that range. NextEra also said it expects adjusted EPS to grow at a compound annual rate of at least 8% through 2032 and is targeting the same growth rate through 2035, off the 2025 base.
NextEra also plans to continue rewarding its shareholders with higher dividends. The company expects its dividend per share to grow at a roughly 10% annual rate through 2026, off the 2024 base. It expects the dividend to grow 6% a year through 2028 from the 2026 base.
The EPS and dividend growth projections give investors a financial foundation for evaluating the Dominion deal. NextEra does not need Dominion simply to prevent a growth slowdown. Instead, it's looking to add another growth engine through the acquisition.
#dominion #rate
2 months ago
For custom chip designer Broadcom Inc. (NASDAQ:AVGO), the debate is all about whether the demand for AI products will sustain and grow. It is among the few firms capable of designing custom AI chips that big technology firms rely on to supplement NVIDIA's high-power and expensive AI chips. Anthropic CEO Dario Amodei's latest remarks about the need to slow down AI development due to safety concerns have generated quite a buzz, and Cramer discussed what Broadcom Inc. (NASDAQ:AVGO)'s CEO told him when asked about AI infrastructure development losing traction:
"What's refuted by Hock Tan, of course, maybe Hock Tan is one of the biggest providers of semis, other than NVIDIA, and when I asked him about, give me a prediction about the AI slowdown, would there be one, he said, not in the least. We see the demand for compute infrastructure for development of AI and inference as extremely strong and durable. So I know those stocks were the most heavily hammered, other than the fiber stocks. But David, when you listen to what Hock Tan said last night on Mad Money, you are inclined to do buying.
"I think David, you recognize, and a lot of people don't, when you're speaking about Hock Tan, whom I had on, you're talking about a 1.6 trillion dollar company. This isn't just someone. . .worried about what orders are going to be. . .this man has more orders than almost anybody other than Jensen Huang. So I think Carl, when we get very, very negative we still have to rely on the facts And the facts do not support there are some people who are very worried about mankind, I did not get the mankind worry when I spoke yesterday."
The CNBC TV host's remarks about Broadcom Inc. (NASDAQ:AVGO) sit right at the center of the debate for the firm. This debate is about whether it will be able to continue to capture additional orders for custom AI chips. Looking at the third quarter earnings, released on September 2nd, the growth narrative appears to be quite strong.
It boosts Cramer's claims of Broadcom Inc. (NASDAQ:AVGO) experiencing strong orders, as during the quarter, the firm's revenue grew by 86%, AI semiconductor revenue jumped by 221% and fiscal year 2026 guidance implied 186% annual AI revenue growth. Not to mention, CEO Tan reaffirmed that Broadcom Inc. (NASDAQ:AVGO) could pull in $115 billion in annual AI chip sales in 2027 and a whopping $230 billion in 2028.
#orders #debate #strong
"What's refuted by Hock Tan, of course, maybe Hock Tan is one of the biggest providers of semis, other than NVIDIA, and when I asked him about, give me a prediction about the AI slowdown, would there be one, he said, not in the least. We see the demand for compute infrastructure for development of AI and inference as extremely strong and durable. So I know those stocks were the most heavily hammered, other than the fiber stocks. But David, when you listen to what Hock Tan said last night on Mad Money, you are inclined to do buying.
"I think David, you recognize, and a lot of people don't, when you're speaking about Hock Tan, whom I had on, you're talking about a 1.6 trillion dollar company. This isn't just someone. . .worried about what orders are going to be. . .this man has more orders than almost anybody other than Jensen Huang. So I think Carl, when we get very, very negative we still have to rely on the facts And the facts do not support there are some people who are very worried about mankind, I did not get the mankind worry when I spoke yesterday."
The CNBC TV host's remarks about Broadcom Inc. (NASDAQ:AVGO) sit right at the center of the debate for the firm. This debate is about whether it will be able to continue to capture additional orders for custom AI chips. Looking at the third quarter earnings, released on September 2nd, the growth narrative appears to be quite strong.
It boosts Cramer's claims of Broadcom Inc. (NASDAQ:AVGO) experiencing strong orders, as during the quarter, the firm's revenue grew by 86%, AI semiconductor revenue jumped by 221% and fiscal year 2026 guidance implied 186% annual AI revenue growth. Not to mention, CEO Tan reaffirmed that Broadcom Inc. (NASDAQ:AVGO) could pull in $115 billion in annual AI chip sales in 2027 and a whopping $230 billion in 2028.
#orders #debate #strong
2 months ago
In June, ****** eX (NASDAQ: SPCX) successfully completed its blockbuster IPO, raising more than $85 billion. In the days that followed, ****** eX's market cap soared from an initial IPO valuation of $1.77 trillion to nearly $2.8 trillion. Shares corrected hard after the surge, however, and ****** eX's valuation now hovers just below $2 trillion -- a 36% decline versus the company's all-time high.
Morgan Stanley (NYSE: MS) ****** ysts remain unfazed regarding the ****** e stock's long-term growth potential. On Sept. 15, the bank reiterated its "buy" rating on shares, affirming its $300 price target. That price target implies more than 100% in near-term upside over the next 12 months.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Why does Morgan Stanley remain so bullish? The answer might surprise you.
Morgan Stanley appears all-in on the ****** e economy. The bank, in many ways, predicted ****** eX's meteoric rise years before much of the public caught on.
#trillion #valuation
Morgan Stanley (NYSE: MS) ****** ysts remain unfazed regarding the ****** e stock's long-term growth potential. On Sept. 15, the bank reiterated its "buy" rating on shares, affirming its $300 price target. That price target implies more than 100% in near-term upside over the next 12 months.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Why does Morgan Stanley remain so bullish? The answer might surprise you.
Morgan Stanley appears all-in on the ****** e economy. The bank, in many ways, predicted ****** eX's meteoric rise years before much of the public caught on.
#trillion #valuation
2 months ago
Interested in Ally Financial Inc.? Here are five stocks we like better.
Ally Financial reaffirmed its full-year net interest margin guidance of 3.6% to 3.7%, supported by balance-sheet growth in higher-yielding retail auto and Corporate Finance loans. However, about $20 million in third-quarter lease losses tied to recalled Stellantis vehicles is expected to keep sequential margin growth roughly flat.
Stellantis-related lease pressure is expected to persist through 2026 but ease in 2027 as Ally's lease portfolio becomes more diversified and protected leases begin to mature. Ally also reaffirmed its 2026 retail auto net charge-off guidance of 1.8% to 2%.
Ally reported growth across its core businesses, including a 7% year-over-year increase in deposit customers and roughly 25% loan growth in Corporate Finance since launching Focus Forward. The company maintained guidance for 3% to 5% average earning-asset growth and approximately 1% operating-expense growth while continuing capital returns.
OneMain's Yield Comes With a Catch
#year #stellantis
Ally Financial reaffirmed its full-year net interest margin guidance of 3.6% to 3.7%, supported by balance-sheet growth in higher-yielding retail auto and Corporate Finance loans. However, about $20 million in third-quarter lease losses tied to recalled Stellantis vehicles is expected to keep sequential margin growth roughly flat.
Stellantis-related lease pressure is expected to persist through 2026 but ease in 2027 as Ally's lease portfolio becomes more diversified and protected leases begin to mature. Ally also reaffirmed its 2026 retail auto net charge-off guidance of 1.8% to 2%.
Ally reported growth across its core businesses, including a 7% year-over-year increase in deposit customers and roughly 25% loan growth in Corporate Finance since launching Focus Forward. The company maintained guidance for 3% to 5% average earning-asset growth and approximately 1% operating-expense growth while continuing capital returns.
OneMain's Yield Comes With a Catch
#year #stellantis
2 months ago
On September 4, the U.S. Department of War (DoW) announced a $336,112,000 Navy contract for Huntington Ingalls Industries, Inc. (NYSE:HII) to advance procurement of long-lead materials for the construction of the future USS William J. Clinton (CVN 82).
Work on the program will be executed in Newport News, Virginia, with completion anticipated by March 2039. Shipbuilding and conversion funding from FY 2026 will be obligated at the time of award.
The contract is not just a headline number, but reaffirms the company's status as the sole nuclear carrier builder for the U.S. Navy.
The long lead materials contract has secured Huntington Ingalls Industries, Inc. (NYSE:HII)'s role on the CVN 82 well before construction begins, which has extended revenue visibility to 2039.
According to defense websites, the Navy plans on spending $22.34 billion on its aircraft carrier replacement program over the next five years. This contract can be seen as among the first in a larger sequence, with more awards to come as procurement accelerates.
#navy #contract #ingalls #industries
Work on the program will be executed in Newport News, Virginia, with completion anticipated by March 2039. Shipbuilding and conversion funding from FY 2026 will be obligated at the time of award.
The contract is not just a headline number, but reaffirms the company's status as the sole nuclear carrier builder for the U.S. Navy.
The long lead materials contract has secured Huntington Ingalls Industries, Inc. (NYSE:HII)'s role on the CVN 82 well before construction begins, which has extended revenue visibility to 2039.
According to defense websites, the Navy plans on spending $22.34 billion on its aircraft carrier replacement program over the next five years. This contract can be seen as among the first in a larger sequence, with more awards to come as procurement accelerates.
#navy #contract #ingalls #industries
2 months ago
On September 8, 2026, CNBC reported that Novartis AG (NYSE:NVS) shares fell about 10% after the company said its experimental drug del-desiran failed to meet its primary goal in a late-stage trial for myotonic dystrophy type 1.
It marked the company's third clinical setback in a week following the earlier failure of cardiovascular drug pelacarsen and a separate pause of eight trials of cell therapy rap-cel after three patient deaths. The decline erased roughly 24 billion Swiss francs, or about $29.6 billion, in market value and put Novartis on pace for one of its worst trading days in company history.
Remibrutinib provides a major remaining pipeline catalyst since Novartis AG (NYSE:NVS) reported successful late-stage results for remibrutinib in multiple sclerosis. It gives investors a credible growth driver after the failures of pelacarsen and del-desiran. The business expects more remibrutinib data later this year, making the drug an important test of whether its remaining pipeline can help long-term growth.
Novartis still expects 5% to 6% annual sales growth through 2030. Management reaffirmed its full-year financial guidance and maintained its target for 5% to 6% compound annual sales growth from 2025 through 2030. That guidance shows the company still expects its overall portfolio and remaining pipeline ******* ets to offset pressure from aging drugs.
The company retains a diversified commercial portfolio. The del-desiran failure removes a potentially important future revenue contributor, but Novartis still makes substantial revenue from its existing medicines. It also retains other pipeline ******* ets. That diversification gives the firm financial capacity to absorb individual clinical failures while it rebuilds investor confidence in its growth pipeline.
#company #remibrutinib
It marked the company's third clinical setback in a week following the earlier failure of cardiovascular drug pelacarsen and a separate pause of eight trials of cell therapy rap-cel after three patient deaths. The decline erased roughly 24 billion Swiss francs, or about $29.6 billion, in market value and put Novartis on pace for one of its worst trading days in company history.
Remibrutinib provides a major remaining pipeline catalyst since Novartis AG (NYSE:NVS) reported successful late-stage results for remibrutinib in multiple sclerosis. It gives investors a credible growth driver after the failures of pelacarsen and del-desiran. The business expects more remibrutinib data later this year, making the drug an important test of whether its remaining pipeline can help long-term growth.
Novartis still expects 5% to 6% annual sales growth through 2030. Management reaffirmed its full-year financial guidance and maintained its target for 5% to 6% compound annual sales growth from 2025 through 2030. That guidance shows the company still expects its overall portfolio and remaining pipeline ******* ets to offset pressure from aging drugs.
The company retains a diversified commercial portfolio. The del-desiran failure removes a potentially important future revenue contributor, but Novartis still makes substantial revenue from its existing medicines. It also retains other pipeline ******* ets. That diversification gives the firm financial capacity to absorb individual clinical failures while it rebuilds investor confidence in its growth pipeline.
#company #remibrutinib
2 months ago
On September 2, 2026, Phreesia, Inc. (NYSE:PHR) reported second-quarter fiscal 2027 results for the period ended July 31, 2026. Revenue rose 10% to $129.5 million and adjusted EBITDA climbed to $32.9 million from $22.1 million a year earlier, a 25% margin. Net income reached $1.9 million, marking the company's fifth consecutive quarter of profitability. Management reaffirmed full-year revenue guidance of $510 million to $520 million and adjusted EBITDA of $125 million to $135 million.
The disagreement on Wall Street is about what that reaffirmation actually signals.
Wells Fargo found the highlight in Network Solutions, which grew 9% year-over-year, and pointed to the ProviderConnect pilot delivering a 4% prescription lift in a GLP-1 campaign that management says is generating follow-on business; the firm raised its target on Phreesia, Inc. (NYSE:PHR) to $10 from $9 while holding an Equal Weight rating.
DA Davidson stayed at Buy despite trimming its target on Phreesia, Inc. (NYSE:PHR) to $13 from $14, arguing the stock sold off on a reiterated guide even though network solutions activity is tracking more encouragingly than the prior outlook and AccessOne is opening a growing opportunity in alternative consumer payment options.
Baird ******* yst Joe Vruwink lifted his target to $11 from $10 at Neutral after updating his model.
#million #solutions
The disagreement on Wall Street is about what that reaffirmation actually signals.
Wells Fargo found the highlight in Network Solutions, which grew 9% year-over-year, and pointed to the ProviderConnect pilot delivering a 4% prescription lift in a GLP-1 campaign that management says is generating follow-on business; the firm raised its target on Phreesia, Inc. (NYSE:PHR) to $10 from $9 while holding an Equal Weight rating.
DA Davidson stayed at Buy despite trimming its target on Phreesia, Inc. (NYSE:PHR) to $13 from $14, arguing the stock sold off on a reiterated guide even though network solutions activity is tracking more encouragingly than the prior outlook and AccessOne is opening a growing opportunity in alternative consumer payment options.
Baird ******* yst Joe Vruwink lifted his target to $11 from $10 at Neutral after updating his model.
#million #solutions
2 months ago
GE Vernova Inc (NYSE:GEV) rebounded with Bernstein's backing after an earlier sell-off that followed broader concerns about technology infrastructure spending.
Shares were up 6% at $933.94 during afternoon trading on Wednesday, outpacing the utilities sector's reported 1.24% advance.
GE Vernova also ranked among the three leading stocks by turnover in the utilities sector as its shares recovered from prior-session declines.
Bernstein reaffirmed its "outperform" rating, highlighting electrification demand beyond immediate artificial intelligence data center needs.
The brokerage said utility-driven power grid upgrades, energy security and decarbonization initiatives accounted for the majority of electrification orders.
#backing
Shares were up 6% at $933.94 during afternoon trading on Wednesday, outpacing the utilities sector's reported 1.24% advance.
GE Vernova also ranked among the three leading stocks by turnover in the utilities sector as its shares recovered from prior-session declines.
Bernstein reaffirmed its "outperform" rating, highlighting electrification demand beyond immediate artificial intelligence data center needs.
The brokerage said utility-driven power grid upgrades, energy security and decarbonization initiatives accounted for the majority of electrification orders.
#backing
2 months ago
Alluvium ******* et Management, an ******* et management company, released its "Conventum – Alluvium Global Fund" second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined 1.4% in EUR terms, 2.2% in USD terms, and 3.9% in AUD terms. Portfolio results were mixed, with Alphabet benefiting from strong Cloud growth, while Robert Half, H&R Block, and other holdings posted solid gains. However, cable businesses and several healthcare and consumer holdings weighed on performance. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Conventum – Alluvium Global Fund highlighted HCA Healthcare, Inc. (NYSE:HCA). HCA Healthcare, Inc. (NYSE:HCA) owns and operates hospitals and related healthcare entities. On September 15, 2026, HCA Healthcare, Inc. (NYSE:HCA) closed at $423.04 per share. HCA Healthcare, Inc. (NYSE:HCA) returned 3.93% over the past month, and its shares are up 5.92% over the past year. HCA Healthcare, Inc. (NYSE:HCA) has a market capitalization of $91.76 billion.
Conventum – Alluvium Global Fund stated the following regarding HCA Healthcare, Inc. (NYSE:HCA) in its Q2 2026 investor letter:
"Our two healthcare companies had a poor quarter (in terms of share price performance, not business fundamentals). HCA Healthcare, Inc. (NYSE:HCA), the hospital operator, fell 17.5%. The share price fell 8.8% immediately following its first quarter results (despite management reaffirming its 2026 guidance). We suspect this is a (over) reaction to poorer than expected respiratory volumes due to a mild flu season. With the shares trading at a discount to our valuation we bought a little more to bring the Fund's position to 6.4%."
HCA Healthcare, Inc. (NYSE:HCA) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 75 hedge fund portfolios held HCA Healthcare, Inc. (NYSE:HCA) at the end of the second quarter which was 70 in the previous quarter. While we acknowledge the potential of HCA Healthcare, Inc. (NYSE:HCA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#quarter #fund #alluvium #conventum
In its second-quarter 2026 investor letter, Conventum – Alluvium Global Fund highlighted HCA Healthcare, Inc. (NYSE:HCA). HCA Healthcare, Inc. (NYSE:HCA) owns and operates hospitals and related healthcare entities. On September 15, 2026, HCA Healthcare, Inc. (NYSE:HCA) closed at $423.04 per share. HCA Healthcare, Inc. (NYSE:HCA) returned 3.93% over the past month, and its shares are up 5.92% over the past year. HCA Healthcare, Inc. (NYSE:HCA) has a market capitalization of $91.76 billion.
Conventum – Alluvium Global Fund stated the following regarding HCA Healthcare, Inc. (NYSE:HCA) in its Q2 2026 investor letter:
"Our two healthcare companies had a poor quarter (in terms of share price performance, not business fundamentals). HCA Healthcare, Inc. (NYSE:HCA), the hospital operator, fell 17.5%. The share price fell 8.8% immediately following its first quarter results (despite management reaffirming its 2026 guidance). We suspect this is a (over) reaction to poorer than expected respiratory volumes due to a mild flu season. With the shares trading at a discount to our valuation we bought a little more to bring the Fund's position to 6.4%."
HCA Healthcare, Inc. (NYSE:HCA) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 75 hedge fund portfolios held HCA Healthcare, Inc. (NYSE:HCA) at the end of the second quarter which was 70 in the previous quarter. While we acknowledge the potential of HCA Healthcare, Inc. (NYSE:HCA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#quarter #fund #alluvium #conventum
2 months ago
Interested in Truist Financial Corporation? Here are five stocks we like better.
Truist will sell its $5.5 billion near-prime auto loan portfolio and exit its Regional Acceptance Corporation business, which was roughly break-even despite high loan yields. The transaction is expected to modestly improve earnings, tangible book value and credit metrics.
The bank reaffirmed its financial outlook, including third-quarter net interest income growth of about 1.5%, full-year growth of 1% to 1.5%, and its $5 billion share-repurchase plan. The sale is expected to generate approximately $950 million in capital but reduce net interest margin by 4 to 5 basis points.
New CEO Mike Lyons is accelerating a broader portfolio and capital-allocation review, with Truist emphasizing relationship banking, deposits, commercial lending, payments, wealth management and potentially credit cards, mortgages and home equity lending.
Smart Money Shifts: U.S. Bancorp Pairs Tech With Yield
#truist #financial #loan #credit
Truist will sell its $5.5 billion near-prime auto loan portfolio and exit its Regional Acceptance Corporation business, which was roughly break-even despite high loan yields. The transaction is expected to modestly improve earnings, tangible book value and credit metrics.
The bank reaffirmed its financial outlook, including third-quarter net interest income growth of about 1.5%, full-year growth of 1% to 1.5%, and its $5 billion share-repurchase plan. The sale is expected to generate approximately $950 million in capital but reduce net interest margin by 4 to 5 basis points.
New CEO Mike Lyons is accelerating a broader portfolio and capital-allocation review, with Truist emphasizing relationship banking, deposits, commercial lending, payments, wealth management and potentially credit cards, mortgages and home equity lending.
Smart Money Shifts: U.S. Bancorp Pairs Tech With Yield
#truist #financial #loan #credit
2 months ago
Klarna stock has cratered 51% year to date and 32% in just the past month, trading near its 52-week low of $12.
While KLAR collapsed, Sezzle surged 87% and Affirm slipped just 3%, signaling Klarna's pain is company-specific, not a BNPL sector rout.
Klarna's Q2 showed transaction margin up 42% and a swing to $9M net profit, but a guidance cut and accounting changes cloud the Q3 outlook.
Just released. Our ****** ysts combed the entire stock market and named the ten best stocks to buy right now, and Klarna Group plc didn't make the cut. Enter your email to see the names that beat KLAR. The report is free. Enter your email and see if any of your stocks made the cut.
Shares of Klarna (NYSE:KLAR) are trading at $14.23 on Tuesday afternoon, leaving the buy now, pay later (BNPL) lender down 51% year to date. Klarna stock is also down 32% over the past month, meaning much of the damage has landed recently rather than fading out.
#klar #year #month
While KLAR collapsed, Sezzle surged 87% and Affirm slipped just 3%, signaling Klarna's pain is company-specific, not a BNPL sector rout.
Klarna's Q2 showed transaction margin up 42% and a swing to $9M net profit, but a guidance cut and accounting changes cloud the Q3 outlook.
Just released. Our ****** ysts combed the entire stock market and named the ten best stocks to buy right now, and Klarna Group plc didn't make the cut. Enter your email to see the names that beat KLAR. The report is free. Enter your email and see if any of your stocks made the cut.
Shares of Klarna (NYSE:KLAR) are trading at $14.23 on Tuesday afternoon, leaving the buy now, pay later (BNPL) lender down 51% year to date. Klarna stock is also down 32% over the past month, meaning much of the damage has landed recently rather than fading out.
#klar #year #month
2 months ago
Enova International Inc (NYSE:ENVA) withdrew regulatory applications for its planned Grasshopper Bancorp acquisition on Tuesday, sending shares sharply lower despite reaffirmed growth forecasts and plans for faster buybacks.
Shares fell 25% to $169.50 following the company's acquisition update.
The technology and ******* ytics company pulled applications with the Office of the Comptroller of the Currency and the Federal Reserve after reviewing the transaction and bank approval process.
CEO Steve Cunningham said withdrawing the applications was the best choice for Enova and its shareholders, adding that the company can keep growing without becoming a bank.
He argued that banking rules have not kept pace with the credit needs of consumers and small businesses that banks do not adequately serve.
#acquisition #bank #international
Shares fell 25% to $169.50 following the company's acquisition update.
The technology and ******* ytics company pulled applications with the Office of the Comptroller of the Currency and the Federal Reserve after reviewing the transaction and bank approval process.
CEO Steve Cunningham said withdrawing the applications was the best choice for Enova and its shareholders, adding that the company can keep growing without becoming a bank.
He argued that banking rules have not kept pace with the credit needs of consumers and small businesses that banks do not adequately serve.
#acquisition #bank #international
2 months ago
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Space Exploration Technologies Corp. CEO Elon Musk has reaffirmed that the commercial ***** eflight company will put NVIDIA Corp's orbital AI computing system in ***** e by next year.
On Sunday, user RyanFox.eth took to the social media platform X, referencing an unnamed YouTuber saying that data centers in ***** e could become a reality by 2035 if the cooling aspect were solved. "People really don't get it," the user said.
Don't Miss:
A single bad hire can set a startup back years. Here are the 5 hires founders most often misjudge — and why
#space #exploration
Space Exploration Technologies Corp. CEO Elon Musk has reaffirmed that the commercial ***** eflight company will put NVIDIA Corp's orbital AI computing system in ***** e by next year.
On Sunday, user RyanFox.eth took to the social media platform X, referencing an unnamed YouTuber saying that data centers in ***** e could become a reality by 2035 if the cooling aspect were solved. "People really don't get it," the user said.
Don't Miss:
A single bad hire can set a startup back years. Here are the 5 hires founders most often misjudge — and why
#space #exploration
2 months ago
Broyhill ******* et Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index's 15.1% and the MSCI ACWI Value Index's 10.8%. For the first half, the Composite returned 2.3%, versus 11.5% for the Index. The letter highlights that a significant portion of the shortfall occurred in April due to market dynamics and geopolitical events, with tech, particularly semiconductors, driving recent gains. Broyhill notes its lack of direct semiconductor exposure but acknowledges potential interest in the sector if opportunities arise, maintaining its investment philosophy focused on capital protection in fragile market conditions. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Broyhill ******* et Management highlighted Sotera Health Company (NASDAQ:SHC). Sotera Health Company (NASDAQ:SHC), a US-based company that provides sterilization solutions, lab testing, and advisory services for the healthcare industry, contributed positively to the portfolio's performance this quarter. On September 14, 2026, Sotera Health Company (NASDAQ:SHC) closed at $18.52 per share, reflecting a market capitalization of $5.29 billion. Sotera Health Company (NASDAQ:SHC) posted a one-month return of 0.05%, while its shares gained 13.62% over the past 52 weeks.
Broyhill ******* et Management stated the following regarding Sotera Health Company (NASDAQ:SHC) in its Q2 2026 investor letter:
"Sotera Health Company (NASDAQ:SHC) was our largest contributor, with shares gaining 25%. We bought it in the first quarter, when the litigation docket was the only thing anyone wanted to discuss, and the price gave no weight to the fact that there are only two companies of scale doing this work. Results beat on revenue, adjusted EBITDA, and earnings per share; guidance was reaffirmed across every line, and management described March as its best volume month in three to four years. The EPA has proposed a full repeal of the 2024 ethylene oxide standard. At the time, the shares traded at roughly 14x forward earnings against 20x for the closest comparable."
Sotera Health Company (NASDAQ:SHC) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 43 hedge fund portfolios held Sotera Health Company (NASDAQ:SHC) at the end of the second quarter, compared to 42 in the previous quarter. While we acknowledge the potential of Sotera Health Company (NASDAQ:SHC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#sotera #broyhill #second
In its second-quarter 2026 investor letter, Broyhill ******* et Management highlighted Sotera Health Company (NASDAQ:SHC). Sotera Health Company (NASDAQ:SHC), a US-based company that provides sterilization solutions, lab testing, and advisory services for the healthcare industry, contributed positively to the portfolio's performance this quarter. On September 14, 2026, Sotera Health Company (NASDAQ:SHC) closed at $18.52 per share, reflecting a market capitalization of $5.29 billion. Sotera Health Company (NASDAQ:SHC) posted a one-month return of 0.05%, while its shares gained 13.62% over the past 52 weeks.
Broyhill ******* et Management stated the following regarding Sotera Health Company (NASDAQ:SHC) in its Q2 2026 investor letter:
"Sotera Health Company (NASDAQ:SHC) was our largest contributor, with shares gaining 25%. We bought it in the first quarter, when the litigation docket was the only thing anyone wanted to discuss, and the price gave no weight to the fact that there are only two companies of scale doing this work. Results beat on revenue, adjusted EBITDA, and earnings per share; guidance was reaffirmed across every line, and management described March as its best volume month in three to four years. The EPA has proposed a full repeal of the 2024 ethylene oxide standard. At the time, the shares traded at roughly 14x forward earnings against 20x for the closest comparable."
Sotera Health Company (NASDAQ:SHC) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 43 hedge fund portfolios held Sotera Health Company (NASDAQ:SHC) at the end of the second quarter, compared to 42 in the previous quarter. While we acknowledge the potential of Sotera Health Company (NASDAQ:SHC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#sotera #broyhill #second
2 months ago
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Space Exploration Technologies Corp. CEO Elon Musk has reaffirmed that the commercial ***** eflight company will put NVIDIA Corp's orbital AI computing system in ***** e by next year.
On Sunday, user RyanFox.eth took to the social media platform X, referencing an unnamed YouTuber saying that data centers in ***** e could become a reality by 2035 if the cooling aspect were solved. "People really don't get it," the user said.
Don't Miss:
A single bad hire can set a startup back years. Here are the 5 hires founders most often misjudge — and why
#benzinga #elon
Space Exploration Technologies Corp. CEO Elon Musk has reaffirmed that the commercial ***** eflight company will put NVIDIA Corp's orbital AI computing system in ***** e by next year.
On Sunday, user RyanFox.eth took to the social media platform X, referencing an unnamed YouTuber saying that data centers in ***** e could become a reality by 2035 if the cooling aspect were solved. "People really don't get it," the user said.
Don't Miss:
A single bad hire can set a startup back years. Here are the 5 hires founders most often misjudge — and why
#benzinga #elon
2 months ago
Broyhill ****** et Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index's 15.1% and the MSCI ACWI Value Index's 10.8%. For the first half, the Composite returned 2.3%, versus 11.5% for the Index. The letter highlights that a significant portion of the shortfall occurred in April due to market dynamics and geopolitical events, with tech, particularly semiconductors, driving recent gains. Broyhill notes its lack of direct semiconductor exposure but acknowledges potential interest in the sector if opportunities arise, maintaining its investment philosophy focused on capital protection in fragile market conditions. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Broyhill ****** et Management highlighted Sotera Health Company (NASDAQ:SHC). Sotera Health Company (NASDAQ:SHC), a US-based company that provides sterilization solutions, lab testing, and advisory services for the healthcare industry, contributed positively to the portfolio's performance this quarter. On September 14, 2026, Sotera Health Company (NASDAQ:SHC) closed at $18.52 per share, reflecting a market capitalization of $5.29 billion. Sotera Health Company (NASDAQ:SHC) posted a one-month return of 0.05%, while its shares gained 13.62% over the past 52 weeks.
Broyhill ****** et Management stated the following regarding Sotera Health Company (NASDAQ:SHC) in its Q2 2026 investor letter:
"Sotera Health Company (NASDAQ:SHC) was our largest contributor, with shares gaining 25%. We bought it in the first quarter, when the litigation docket was the only thing anyone wanted to discuss, and the price gave no weight to the fact that there are only two companies of scale doing this work. Results beat on revenue, adjusted EBITDA, and earnings per share; guidance was reaffirmed across every line, and management described March as its best volume month in three to four years. The EPA has proposed a full repeal of the 2024 ethylene oxide standard. At the time, the shares traded at roughly 14x forward earnings against 20x for the closest comparable."
Sotera Health Company (NASDAQ:SHC) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 43 hedge fund portfolios held Sotera Health Company (NASDAQ:SHC) at the end of the second quarter, compared to 42 in the previous quarter. While we acknowledge the potential of Sotera Health Company (NASDAQ:SHC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#letter
In its second-quarter 2026 investor letter, Broyhill ****** et Management highlighted Sotera Health Company (NASDAQ:SHC). Sotera Health Company (NASDAQ:SHC), a US-based company that provides sterilization solutions, lab testing, and advisory services for the healthcare industry, contributed positively to the portfolio's performance this quarter. On September 14, 2026, Sotera Health Company (NASDAQ:SHC) closed at $18.52 per share, reflecting a market capitalization of $5.29 billion. Sotera Health Company (NASDAQ:SHC) posted a one-month return of 0.05%, while its shares gained 13.62% over the past 52 weeks.
Broyhill ****** et Management stated the following regarding Sotera Health Company (NASDAQ:SHC) in its Q2 2026 investor letter:
"Sotera Health Company (NASDAQ:SHC) was our largest contributor, with shares gaining 25%. We bought it in the first quarter, when the litigation docket was the only thing anyone wanted to discuss, and the price gave no weight to the fact that there are only two companies of scale doing this work. Results beat on revenue, adjusted EBITDA, and earnings per share; guidance was reaffirmed across every line, and management described March as its best volume month in three to four years. The EPA has proposed a full repeal of the 2024 ethylene oxide standard. At the time, the shares traded at roughly 14x forward earnings against 20x for the closest comparable."
Sotera Health Company (NASDAQ:SHC) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 43 hedge fund portfolios held Sotera Health Company (NASDAQ:SHC) at the end of the second quarter, compared to 42 in the previous quarter. While we acknowledge the potential of Sotera Health Company (NASDAQ:SHC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#letter
2 months ago
By Lucia Mutikani
WASHINGTON, Sept 16 (Reuters) - U.S. retail sales rebounded sharply in August as households boosted purchases of a range of goods while also spending more at restaurants and bars, reinforcing the economy's resilience even as consumers grow more anxious about high inflation.
The stronger-than-expected report from the Commerce Department on Wednesday prompted economists to upgrade their gross domestic product growth estimates for the third quarter. Together with other data on Wednesday showing a surge in import prices last month, strong demand sealed the argument for a widely anticipated interest rate increase from the Federal Reserve later in the day, economists said.
The reports followed data this month showing producer and consumer prices accelerated in August, while the labor market regained its poise after wobbling through much of summer.
"This reaffirms that the economy is more than capable of handling higher interest rates, providing the Fed plenty of scope to hike to get inflation under control," said Bradley Saunders, North America economist at Capital Economics.
#economists #data #month
WASHINGTON, Sept 16 (Reuters) - U.S. retail sales rebounded sharply in August as households boosted purchases of a range of goods while also spending more at restaurants and bars, reinforcing the economy's resilience even as consumers grow more anxious about high inflation.
The stronger-than-expected report from the Commerce Department on Wednesday prompted economists to upgrade their gross domestic product growth estimates for the third quarter. Together with other data on Wednesday showing a surge in import prices last month, strong demand sealed the argument for a widely anticipated interest rate increase from the Federal Reserve later in the day, economists said.
The reports followed data this month showing producer and consumer prices accelerated in August, while the labor market regained its poise after wobbling through much of summer.
"This reaffirms that the economy is more than capable of handling higher interest rates, providing the Fed plenty of scope to hike to get inflation under control," said Bradley Saunders, North America economist at Capital Economics.
#economists #data #month
2 months ago
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.
Top 5 Upgrades:
Wolfe Research upgraded Paychex (PAYX) to Peer Perform from Underperform without a price target. The firm sees reduced estimate risk for the company amid stable employment trends.
UBS upgraded Union Pacific (UNP) to Buy from Neutral with a price target of $339, up from $310. The firm says its **** ysis of key customer markets points to a second year of strong volume growth in 2027 for Union Pacific.
Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy from Hold with a $9 price target after the FDA reaffirmed the pivotal study design for RP-A501 in Danon Disease, except for a recalibrated dose and prophylaxis.
Needham upgraded Similarweb (SMWB) to Buy from Hold with an $11 price target after meeting with management. Needham was encouraged by AI's potential to increase the value and consumption of Similarweb's data.
#needham #Research #union #pacific
Top 5 Upgrades:
Wolfe Research upgraded Paychex (PAYX) to Peer Perform from Underperform without a price target. The firm sees reduced estimate risk for the company amid stable employment trends.
UBS upgraded Union Pacific (UNP) to Buy from Neutral with a price target of $339, up from $310. The firm says its **** ysis of key customer markets points to a second year of strong volume growth in 2027 for Union Pacific.
Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy from Hold with a $9 price target after the FDA reaffirmed the pivotal study design for RP-A501 in Danon Disease, except for a recalibrated dose and prophylaxis.
Needham upgraded Similarweb (SMWB) to Buy from Hold with an $11 price target after meeting with management. Needham was encouraged by AI's potential to increase the value and consumption of Similarweb's data.
#needham #Research #union #pacific
2 months ago
Alluvium ****** et Management, an ****** et management company, released its "Conventum – Alluvium Global Fund" second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined 1.4% in EUR terms, 2.2% in USD terms, and 3.9% in AUD terms. Portfolio results were mixed, with Alphabet benefiting from strong Cloud growth, while Robert Half, H&R Block, and other holdings posted solid gains. However, cable businesses and several healthcare and consumer holdings weighed on performance. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Conventum – Alluvium Global Fund highlighted HCA Healthcare, Inc. (NYSE:HCA). HCA Healthcare, Inc. (NYSE:HCA) owns and operates hospitals and related healthcare entities. On September 15, 2026, HCA Healthcare, Inc. (NYSE:HCA) closed at $423.04 per share. HCA Healthcare, Inc. (NYSE:HCA) returned 3.93% over the past month, and its shares are up 5.92% over the past year. HCA Healthcare, Inc. (NYSE:HCA) has a market capitalization of $91.76 billion.
Conventum – Alluvium Global Fund stated the following regarding HCA Healthcare, Inc. (NYSE:HCA) in its Q2 2026 investor letter:
"Our two healthcare companies had a poor quarter (in terms of share price performance, not business fundamentals). HCA Healthcare, Inc. (NYSE:HCA), the hospital operator, fell 17.5%. The share price fell 8.8% immediately following its first quarter results (despite management reaffirming its 2026 guidance). We suspect this is a (over) reaction to poorer than expected respiratory volumes due to a mild flu season. With the shares trading at a discount to our valuation we bought a little more to bring the Fund's position to 6.4%."
HCA Healthcare, Inc. (NYSE:HCA) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 75 hedge fund portfolios held HCA Healthcare, Inc. (NYSE:HCA) at the end of the second quarter which was 70 in the previous quarter. While we acknowledge the potential of HCA Healthcare, Inc. (NYSE:HCA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#healthcare #quarter #letter
In its second-quarter 2026 investor letter, Conventum – Alluvium Global Fund highlighted HCA Healthcare, Inc. (NYSE:HCA). HCA Healthcare, Inc. (NYSE:HCA) owns and operates hospitals and related healthcare entities. On September 15, 2026, HCA Healthcare, Inc. (NYSE:HCA) closed at $423.04 per share. HCA Healthcare, Inc. (NYSE:HCA) returned 3.93% over the past month, and its shares are up 5.92% over the past year. HCA Healthcare, Inc. (NYSE:HCA) has a market capitalization of $91.76 billion.
Conventum – Alluvium Global Fund stated the following regarding HCA Healthcare, Inc. (NYSE:HCA) in its Q2 2026 investor letter:
"Our two healthcare companies had a poor quarter (in terms of share price performance, not business fundamentals). HCA Healthcare, Inc. (NYSE:HCA), the hospital operator, fell 17.5%. The share price fell 8.8% immediately following its first quarter results (despite management reaffirming its 2026 guidance). We suspect this is a (over) reaction to poorer than expected respiratory volumes due to a mild flu season. With the shares trading at a discount to our valuation we bought a little more to bring the Fund's position to 6.4%."
HCA Healthcare, Inc. (NYSE:HCA) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 75 hedge fund portfolios held HCA Healthcare, Inc. (NYSE:HCA) at the end of the second quarter which was 70 in the previous quarter. While we acknowledge the potential of HCA Healthcare, Inc. (NYSE:HCA) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#healthcare #quarter #letter
2 months ago
Comedian Bill Maher called Democratic politicians "cowards" while doubling down on his stance that the Sept. 11, 2001, hijackers were not — a position that infamously led to ABC canceling his show more than two decades ago.
In a segment on HBO's "Real Time with Bill Maher" Friday, the comedian reaffirmed his opinion that "the terrorists weren't cowards" which he initially said after the Sept. 11 terrorist attacks.
"I know a guy whose show got canceled just for saying the terrorists weren't cowards. And that guy was right. They weren't cowards, but I'll tell you who is: Democratic Party politicians," Maher said.
He added that this "moral confusion" within the party is most notable when talking about "a place called Gaza."
"A little strip of land that was not part of the original Israel, but which they won in a war launched against them, but then gave back as a peace gesture," he said.
#cowards #democratic #called #politicians
In a segment on HBO's "Real Time with Bill Maher" Friday, the comedian reaffirmed his opinion that "the terrorists weren't cowards" which he initially said after the Sept. 11 terrorist attacks.
"I know a guy whose show got canceled just for saying the terrorists weren't cowards. And that guy was right. They weren't cowards, but I'll tell you who is: Democratic Party politicians," Maher said.
He added that this "moral confusion" within the party is most notable when talking about "a place called Gaza."
"A little strip of land that was not part of the original Israel, but which they won in a war launched against them, but then gave back as a peace gesture," he said.
#cowards #democratic #called #politicians
2 months ago
James Rodríguez's arrival at Atlético Nacional continues to draw major reactions in Colombian football. This time, the club's legendary former goalkeeper and idol, René Higuita, dedicated an emotional welcome message to him, full of affection and verdolaga mystique.
Through his words, the iconic goalkeeper highlighted the institutional weight of the jersey the midfielder from Cúcuta will wear. "This jersey has history, it has heart, and it has fans who are always with us. We love you, welcome to our beloved Atlético Nacional," the former player said.
Higuita ended his greeting by wishing the Colombia national team midfielder the greatest success in this new stage of his professional career: "May the victories come, my brother. Welcome to green," he concluded, reaffirming the enormous excitement this signing has generated among Antioquia's fans.
This article was translated into English by Artificial Intelligence. You can read the original version in 🇪🇸 here.
#tico #fans
Through his words, the iconic goalkeeper highlighted the institutional weight of the jersey the midfielder from Cúcuta will wear. "This jersey has history, it has heart, and it has fans who are always with us. We love you, welcome to our beloved Atlético Nacional," the former player said.
Higuita ended his greeting by wishing the Colombia national team midfielder the greatest success in this new stage of his professional career: "May the victories come, my brother. Welcome to green," he concluded, reaffirming the enormous excitement this signing has generated among Antioquia's fans.
This article was translated into English by Artificial Intelligence. You can read the original version in 🇪🇸 here.
#tico #fans
